Convection shapes the trade-off between antibiotic efficacy and the
  selection for resistance in spatial gradients by Gralka, Matti et al.
Convection shapes the trade-off between antibiotic
efficacy and the selection for resistance in spatial
gradients
Matti Gralka†, Diana Fusco†‡, Stephen Martis† and Oskar
Hallatschek†‡‡
† Department of Physics, University of California, Berkeley, CA 94720
‡ Biophysics and Evolutionary Dynamics Group, Departments of Physics and
Integrative Biology, University of California, Berkeley, CA 94720
Abstract. Since penicillin was discovered about 90 years ago, we have become
used to using drugs to eradicate unwanted pathogenic cells. However, using drugs
to kill bacteria, viruses or cancer cells has the serious side effect of selecting for
mutant types that survive the drug attack. A key question therefore is how one
could eradicate as many cells as possible for a given acceptable risk of drug resistance
evolution. We address this general question in a model of drug resistance evolution in
spatial drug gradients, which recent experiments and theories have suggested as key
drivers of drug resistance. Importantly, our model takes into account the influence of
convection, resulting for instance from blood flow. Using stochastic simulations, we
study the fates of individual resistance mutations and quantify the trade-off between
the killing of wild-type cells and the rise of resistance mutations: shallow gradients
and convection into the antibiotic region promote wild-type death, at the cost of
increasing the establishment probability of resistance mutations. We can explain
these observed trends by modeling the adaptation process as a branching random
walk. Our analysis reveals that the trade-off between death and adaptation depends
on the relative length scales of the spatial drug gradient and random dispersal, and the
strength of convection. Our results show that convection can have a momentous effect
on the rate of establishment of new mutations, and may heavily impact the efficiency
of antibiotic treatment.
‡ To whom correspondence should be addressed.
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1. Introduction
The emergence of drug resistance represents one of the major clinical challenges of
the current century [1–3]. Microbial pathogens quickly acquire resistance to new
antibiotics [4], while solid tumors often regrow after treatment because of resistance
mutations that arise during tumor growth [5]. In addition to genomic studies examining
the molecular causes of resistance [6, 7], the dynamics of drug resistance evolution has
recently attracted wide interest [8, 9], with the dual goal of understanding the emergence
of resistance and developing novel strategies to prevent or control its spread [10, 11].
Next-generation sequencing and high-throughput experimental techniques enable the
quantitative study of resistance evolution but require the development of new theories
to appropriately interpret experimental results [12].
In many realistic systems, an evolving population interacts with its surroundings
and exhibits a well-defined spatial structure (for instance, in tumors and biofilms [5]). It
has recently been shown that this spatial structure can strongly influence the subclonal
structure and the adaptation of spatially expanding populations, both from de novo and
pre-existing mutations [13–15]. In addition, the presence of spatial drug gradients is well
documented both in the outside environment [16, 17] as well as within biofilms [18] and
the human body [19–22]. The presence of spatial [12, 23–27] and temporal [10, 28–30]
heterogeneities has been shown to facilitate the emergence of drug-resistant phenotypes
and enable populations to reach a higher degree of resistance than in homogeneous drug
concentrations. For instance, in a microfluidic experiment, a spatial gradient gave rise to
a higher rate of adaptation of bacterial populations [26]. Similarly, microbes growing on
soft agar plates with gradually increasing antibiotic concentrations were able to rapidly
evolve resistance to high levels of antibiotics, while sudden jumps to unsustainably high
concentrations dramatically slowed down adaptation [12]. Moreover, many realistic
growth scenarios of bacterial populations may be subject to convection driving them up
or down the gradient. Examples include the gut, arteries, and urethra in the human
body [31–34], but also flows in aquatic environments, like ocean and river currents [35],
or flow in pipes and catheters [36].
A number of recent theoretical studies have investigated how gradients speed up
the evolution of drug resistance [37–39]. Greulich et al. [38] considered a population
adapting to a smooth gradient, which gradually lowers the growth rate of susceptible
individuals. Hermsen et al. [37] studied resistance evolution in a series of sharp step-like
increases in concentration, where a novel resistance mutations was necessary for survival
in the next step (the ”staircase” model); Hermsen [39] later proposed a generalization of
the staircase model to continuous gradients. These previous studies focused on the speed
of adaptation, i.e., how quickly the population evolves to tolerate high concentrations of
antibiotics. In the context of the emergence of drug resistance, however, this observable
alone ignores a crucial reality of antibiotic treatment: efficient drug treatment first and
foremost aims to kill as many bacteria as possible, while limiting the rise of resistance
mutation [40, 41]. How this apparent trade-off can be optimized for populations in
Convection shapes resistance evolution in spatial gradients 3
Wild-type
population
c(x)
Antibiotic
concentration
v > 0
v < 0
Random
dispersal D Flow
Figure 1. Sketch of our modeling setup. We assume that, initially, a purely wild-
type population has reached a steady-state density profile (blue) in the presence of a
steady-state antibiotic concentration gradient (orange). Resistance mutations occur
spontaneously in randomly drawn individuals and disperse, proliferate and die until
extinction or ultimate fixation. Convection can either drive the population towards
the antibiotic (co-flow, v > 0) or away from it (counter-flow, v < 0). Our goal is
to analyze the establishment probability of resistance mutation for a given rate of
wild-type killing.
spatial gradients to prevent the evolution of drug resistance has so far been unexplored.
Here, we present simulations, rationalized by a comprehensive analytical framework,
of populations evolving resistance in a variety of spatial antibiotic concentration
gradients and under the influence of convection. We measure the establishment
probability of individual resistant mutants arising in a region occupied by susceptible
wild type and find that successful, ”surfing”, mutations arise in a localized population
patch close to the population front, the size of which depends on the relative strength
of bacterial diffusion, antibiotic gradient steepness, and convection. We find that
shallow gradients and flow towards higher antibiotic concentrations promote wild-type
death, at the cost of increasing the establishment probability of resistance mutations.
Conversely, populations in steep gradients and subject to flow towards lower antibiotic
concentrations give rise to fewer drug-induced wild-type deaths but also produce fewer
resistance mutants. We introduce the notion of a treatment efficiency, which quantifies
this inherent trade-off between adaptation and death, and find it to be strongly
modulated by gradient steepness and convection.
2. Definition of the model
Consider a population in a fixed antibiotic concentration gradient. Where the antibiotic
concentration is too high, the population cannot survive unless it evolves resistance to
the antibiotic, and thus at steady-state, a population density profile c(x) will develop.
For an individual mutation conferring antibiotic resistance that occurs at position x in
the population we define the probability u(x) that this mutation will be successful, i.e.,
establish first locally and eventually colonize areas where the antibiotic concentration
is too high to allow for growth of the wild type. In doing so, we implicitly assume a
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very low mutation rate and neglect clonal interference to focus on the fate of individual
mutations (SI section 6). We come back to this question in the Discussion.
A drug gradient arises upon administering an antibiotic that is introduced at one
location in the system (the source) and flows out of the system at another (the sink). The
antibiotic may be influenced by convection, e.g., through blood flow or peristaltics in the
gut, and be subject to degradation. At steady-state, a concentration gradient between
source and sink is established, which may take a range of shapes, from a sharp, step-
like gradient for strong convection, to a shallow gradient over the whole system size.
Using a simple reaction-diffusion model, we show in the Supplementary Information
(SI section 1) how the gradient depends on the distance between source and sink, the
diffusivity of the antibiotic, and the speed of convection (see SI). To keep the discussion
general, here we approximate the features of a typical antibiotic gradient by modeling
it as a sigmoidal function that changes over a characteristic length scale λ, which sets
the gradient steepness, without trying to associate a particular value of λ with a specific
combination of real-life parameters.
The wild-type population growing in this gradient will in general also be subject
to convection with flow speed v. However, it is important to note this flow speed
may be very different from the convection that affects the antibiotic gradient. As an
example, the flow speed inside a blood vessel depends on the distance from the wall, and
thus, surface-bound populations such as biofilms may experience much lower flow speeds
than antibiotic in the bulk fluid. More generally, it is to be expected that fluid flow
differentially affects bacterial cells and antibiotic molecules due to their different sizes,
potential porosity of the surroundings, adhesion effects, etc, such that convective flows
are arguably the rule rather than the exception. Therefore, without loss of generality, we
may ignore the details of how a particular steady-state antibiotic gradient is generated,
and focus on how the combination of antibiotic gradient and convection shapes the
emergence of resistance.
We model the effect of the antibiotic by a drug-induced death rate b(x) of susceptible
wild-type individuals giving rise to a net growth rate s(x) of the wild type that ranges
from the maximal growth rate a0 (in antibiotic-free regions) to some negative net growth
rate (where the antibiotic concentration is high). For simplicity, we model the death
rate such that at the highest concentration wild-type individuals typically die within one
generation. Given a net growth rate profile, we can compute the steady-state wild-type
population density c(x), whence we obtain the number B of drug-induced wild-type
deaths per generation,
total death rate B =
∑
c(x)b(x). (1)
The total death rate B quantifies the efficacy of the antibiotic; it corresponds to the
rate at which the population is hindered in its growth by the antibiotic. Note that since
we only consider steady-state population densities and thus do not explicitly simulation
the eradication of the wild-type population, our analysis relies on the immune system or
slowly progressing antibiotic concentration gradients to completely eradicate the wild-
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type population [41].
To quantify the emergence of resistance, we measure the local mutant establishment
probability u(x). Since the probability that a mutation occurs in the first place is
proportional to the wild-type population density c(x), it follows that successful mutants
can only arise where both the wild-type population density and the establishment
probability are high (see Fig. 2). A measure for how readily new resistant mutants
establish is thus given by the product of wild-type population density and the
establishment probability [42], summed over the whole population [43]. We call this
measure the rate of adaptation, R,
rate of adaptation R =
∑
c(x)u(x). (2)
The rate of adaptation, R, is proportional to the rate at which new resistance mutations
arise (at a low mutation rate µ, see SI section 6) and establish in the population.
Alternatively, the rate of adaptation, R, can be understood as a measure proportional
to the mean establishment probability
∑
c(x)u(x)/
∑
c(x), i.e., the probability that a
mutation arising anywhere in the population establishes.
Finally, we define the treatment efficiency Q as the ratio of the effective reduction in
growth and the rate of adaptation to the antibiotic: a treatment is deemed particularly
efficient if it can reduce the growth of the wild-type population while at the same time
hindering the emergence of resistant phenotypes as much as possible. In our model, this
corresponds to defining
treatment efficiency Q =
B
R
. (3)
As we shall see below, the rate of adaptation, R, and the total death rate B typically
follow the same trends, e.g., they are both larger in shallow gradients than in steep
ones, as may perhaps be suspected intuitively. By contrast, the treatment efficiency Q
will turn out to be less accessible to intuition and require a detailed understanding of
the population density and establishment probability profiles. In the following, we first
present simulation results and then turn to analytical theory to rationalize our findings.
3. Simulation results
We simulate a population of wild-type individuals on a lattice of L demes, where each
individual can migrate into a neighboring deme, replicate, and die, using a Gillespie
algorithm [44, 45] (see Methods). Wild-type population growth is limited to a carrying
capacity K by a logistic death term [46]. The population is subject to convective
flow with speed v and set in a one-dimensional antibiotic gradient (see the sketch in
Fig. 1), which interpolates between maximal and zero antibiotic concentration over a
characteristic length scale λ. The antibiotic gradient induces a wild-type death rate
b(x), giving rise to an effective growth rate s(x) for the wild-type. For simplicity, we
choose the functional form
s(x) = −a0 tanh (x/λ) , (4)
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Figure 2. Population density c(x) (top row) and establishment probability u(x)
(middle row) for three different concentration profiles (sWT , gray background; (a)
shallow gradient, λ = 100; (b) intermediate gradient λ = 10; (c) step) and different
values of v = −0.4 to 0.6 (v < 0, red tones; v = 0, black; v > 0, cyan tones),
from stepping stone simulations. The bottom row shows the product u(x)c(x), which
identifies the localized region where successful mutants arise.
such that wild-type growth is strongly inhibited for x  0 and proceeds unhindered
with growth rate a0 for x 0.
Following the equilibration to the steady-state profile c(x) of the wild type, a single
resistant mutant is inserted into the population at position x. The resistant mutant has
the same birth rate as the wild type and is subject to the same carrying capacity as
the wild-type, but it does not suffer from an increased death rate due to the antibiotics.
We follow the mutant clone until it either goes extinct or reaches the far end of the
simulation box, in which case we consider the mutant established. The establishment
probability u(x) is then equal to the fraction of simulations in which a mutant introduced
at x managed to establish.
Fig. 2 shows the resulting population density c(x) (top row) and establishment
probability u(x) profiles, for three different gradients (columns). Within each panel,
different colors represent the profiles resulting under different flow speeds. Here, we
adopt the usual convention of positive flow speed pointing to the right, which in our
case corresponds to flow towards high antibiotic concentrations. We will refer to such
flow as co-flow, and represent it graphically in hues of cyan. Conversely, negative flow
speeds point to the right, towards lower antibiotic concentration; we term this counter-
flow and use red tones.
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Figure 3. Quantifying the trade-off between killing of wild-type cells and
establishment of resistant mutants. (a) the total death rate B and the rate of
adaptation, R, for different antibiotic gradients (shallow gradient, λ = 100, green;
intermediate gradient, λ = 10, blue; step, purple). Counter-flow (v < 0) leads to
drastic decrease of both B and R, while co-flow has a milder effect, in accordance
with the individual population and establishment probability profiles in Fig. 2. (b)
The treatment efficiency Q, defined as the number B of drug-induced deaths per
generation divided by the rate of adaptation, R, (see eq. 3). Counter-flow can increase
the treatment efficiency by an order of magnitude in shallow gradients because R is
reduced by the effect of convection on both u(x) and c(x), while B only captures
changes in c(x).
In the absence of convection, shown in black, the wild-type population density c(x)
roughly follows the net growth rate sWT (x) (gray dotted line), and the establishment
probability u(x) is generally high where c(x) is low, and vice-versa, since the mutants
compete for resources with the wild-type.
Convection affects the wild-type population density profile as intuitively expected,
by stretching or compressing the population spatial range for co-flow and counter-flow,
respectively. Interestingly, while counter-flow significantly alters the profile, the effects
of co-flow are hindered by the drug profile, which prevents the wild-type from growing
too far into the antibiotic region.
The effect of convection on the establishment probability is more complex, due
to the generation of two competing processes that either help or hinder the mutant
success. On the one hand, the changes in the wild-type profile described above alter
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the competition with the mutants, reducing the establishment probability in co-flow
conditions, and increasing it in counter-flow conditions. On the other hand, mutants
are also transported towards the direction of flow: their success rate is thus increased
by co-flow and reduced by counter-flow. The presence of these two opposing forces
generates interesting cut-offs along the profile, which we characterize in the Theory
section.
The relative strength of the two competing effects can be quantified by the product
u(x)c(x), which represents the probability density of successful mutants (bottom row in
Fig. 2). Here we see that co-flow widens the probability peak, while counter-flow shrinks
it and moves it away from the antibiotic region. This suggests that transportation of
the mutants in the direction of flow rather than competition with the wild-type is the
dominant effect in the mutant success rate. Since the area under these curves is the rate
of adaptation, R, defined in eq. 2, we find that both the rate of adaptationand the total
death rate B are higher in co-flow conditions and shallow gradients and lower in steep
gradient with counter-flow, as shown in Fig. 3a. Although R and B follow the same
rough trends with flow speed v, the rate of adaptation, R, is generally more strongly
affected by flow than the total death rate B. This is because flow alters both c(x) and
u(x), but leaves the local death rates b(x) unchanged.
This has dramatic effects on the treatment efficiency Q = B/R, shown in Fig. 3b.
Shallow gradients are generally conducive to a larger treatment efficiency Q than steep
gradients. In particular, strong counter-flow conditions (v < 0) in shallow gradients give
rise to very small R compared to B, such that the treatment efficiency can be more than
an order of magnitude larger than in the no-flow case. In steep gradients, although both
R and B change over two orders of magnitude for different flow speeds, the treatment
efficiency Q remains roughly constant because both R and B are equally affected by
flow (Fig. 3a, purple lines).
In summary, our simulations show that the population density profile c(x) as well
as the local establishment probability u(x) of resistance mutants are both strongly
influenced by environmental parameters, in particular, by the steepness of the antibiotic
gradient and the strength of convection. In the following, we lay out a mathematical
model based on the theory of branching random walks that reproduces our key findings
and elucidates the relative roles of gradient steepness and flow speed; detailed calculation
are mostly relegated to the Supplementary Information.
4. Theory
4.1. General framework
We assume that the wild-type population density c(x, t) (rescaled by the carrying
capacity K) is described by the reaction-diffusion equation [47]
∂tc(x, t) = D∂
2
xc− v∂xc+ sWT (x)c− aWT (x)c2, (5)
where aWT (x) is the local wild type birth rate, bWt is the local antibiotic-induced death
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Figure 4. The analytical model is in good agreement with the simulation results. (a)
Population density c(ξ) (blue) and establishment probability u(ξ) profiles for a step-
like antibiotic profile without external flow. Symbols are simulations, solid lines are
numerical solutions to eqs. 5 and 7, dashed lines are analytical solution, eqs. S7 and S9.
(b) Co-flow (ν > 0, cyan) gives rise to broader algebraic establishment probability
profiles, while counter-flow (ν < 0) gives rise to an exponential decrease. Both cases
are asymptotically captured by the analytical approximations (solid lines, eqs. S9, S15
and S16.
rate, sWT (x) = aWT (x)− bWT (x) is the local net growth rate of the wild type, and v is
the external flow speed, representing, e.g., blood flow. This model is a straight-forward
generalization for the standard Fisher model [48] to spatially inhomogeneous growth
rates. Our model ensures that the steady-state local population density cSS depends
explicitly on the local death rate bWT (x) when the death and birth rate profiles change
sufficiently slowly in space,
cSS(x) = 1− bWT (x)
aWT (x)
. (6)
Our model, like the original Fisher equation, ignores the discrete nature of individuals,
which has been shown to significantly alter the tip of the population front [49, 50],
especially when the carrying capacity is small [51] (see SI section 5 for a detailed
discussion). Nevertheless, we expect good agreement between our model and simulations
in terms of the total death rate B and the rate of adaptation, R, , whose values do not
significantly depend on the population profile at the tip of the front.
Given a single resistance mutation arises in the population at position x, its
probability u(x, t) to survive for a time t can be derived by modeling the mutant
lineage as a branching random walk; it obeys a nonlinear reaction-diffusion equation
(see Ref. [43] and SI section 2),
∂tu(x, t) = D∂
2
xu+ v∂xu+ sMT (x)u− aMT (x)u2, (7)
where aMT (x) is the local birth rate of the mutants and sMT (x) = aMT (x) − bMT (x)
is their net growth rate. The establishment probability u(x), i.e., the ultimate survival
probability for a mutation born at position x, as measured in simulations, is given by
the steady-state solution of eq. 7.
To mimic the situation in our simulations, we assume that the birth rate of wild-
type and mutant is identical and constant, aWT (x) = aMT (x) = a0, while the wild-type
drug-induced death rate bWT (x) ranges from −a0 to a0. This implies that effect of the
Convection shapes resistance evolution in spatial gradients 10
antibiotic is to increase the death rate of the wild type, while the drug-induced death
rate of the resistant mutant is zero. The effective growth rate of the mutants is thus
determined purely through competition with the wild type, i.e., sMT(x) = a0[1− c(x)].
To model random dispersal and external flow, we have included diffusion and convection
terms in eqs. 5 and 7 (note the difference in sign between the convection terms). To get
a feel for solution to the set of equations 5 and 7, we first study the case v = 0 before
turning on convection (v 6= 0).
4.2. No flow
We begin by considering the simplest functional form for the antibiotic gradient – a
step-like increase in concentration at x = 0 that gives rise a net growth rate of a0 for
x < 0 and −a0 for x > 0, i.e.,
sMT (x) = a0 [1− 2Θ(ξ)] . (8)
Such a sharp gradient could emerge, for instance, at the boundary of different tissues or
organs with different affinities to store antibiotics [19, 25]. Upon rescaling the spatial
coordinate by the characteristic length scale ` =
√
D/a0, which can be intuitively
understood as the typical distance that a mutant individual travels through random
dispersal before replicating, eq. 5 for the wild-type population density in this case
becomes
0 = ∂2ξ c+ [1− 2Θ(ξ)]c− c2 (9)
where ξ = x/`. Its solution, given analytically in SI section 3, transitions quickly from
1 to 0 over a distance ∼ 2` (Fig. 4a).
To find the establishment probability u(ξ) far from the transition, we solve
0 = ∂2ξu+ [1− c(ξ)]u− u2, (10)
which, given the exact solution c(ξ), can simply be integrated numerically (see Methods).
To make analytical progress, we approximate the wild-type population density with a
step, i.e., c(ξ) ≈ Θ(−ξ) and ask for solutions to eq. 10 far from the transition region.
For ξ > 0, u(ξ) also approaches 1 exponentially quickly over a distance `, since the
lack of competition with the wild-type in this region facilitates the establishment of
resistance mutations. Instead, far inside the bulk of the population (ξ < 0), we find
that the establishment probability exhibits a long tail, u(ξ) ∼ ξ−2 (Fig. 4a). The long
tail implies that mutations arising deep inside the bulk of the population still have a
relatively high chance of establishing, which explain the asymmetry of the simulation
curves in Fig. 2c.
For gradients varying over length scales longer than `, we model gradients decaying
over a characteristic length scale λ with a net growth rate s(ξ) of the form eq. 4.
Introducing the steepness parameter m = `/λ, which quantifies the relative length scales
associated with diffusion and drug gradient, we can write the steady-state equation for
the wild-type population density as
0 = ∂2ξ c+ tanh(−mξ)c− c2. (11)
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Figure 5. In shallow gradients, counter-flow gives rise to sharp cut-offs in the
population density (ξ∗c ) and establishment probability (ξ
∗
u) profiles (see Fig. 2a). The
cut-off positions are well-captured by the analytical approximations (solid lines, eqs. 15
and 16). Squares are cut-offs extracted from simulation, dots and dotted line from
numerical solutions to eq. 5 and 7 without and with a growth rate cut-off (SI section 5).
While eq. 11 does not have an analytical solution, we can change variables to ξ′ = ξm
to see that the diffusion term in eq. 11 can be neglected when m  1 and thus
c(ξ) ≈ sWT (ξ). More generally, for mutants in shallow gradients with a mutant net
growth rate sMT (ξ) (see eq. 7), we get the eventual establishment probability of the
familiar form
u(ξ) =
sMT (ξ)
aMT (ξ)
. (12)
This so-called quasi-static approximation is a straight-forward extrapolation of the well-
mixed result and has been used to model the establishment probability by Greulich et
al. [38].
Once solutions for c(ξ) and u(ξ) are found, they can be used to compute the rate
of adaptation, R, and total death rate B. We find asymptotically
R ≈
{
1.91`, for λ `,
(1− ln 2)λ, for λ `, (13)
and
B ≈
{
0.38`, for λ `,
(1− ln 2)λ, for λ `, (14)
which agrees well with the numerical result in the two limiting cases λ ` and λ `
(Fig. 6). Thus, the treatment efficiency Q is constrained to a relatively small range in
the absence of convection.
Co-flow and counter-flow
We now investigate the influence of convection on the population density c(x), the
establishment probability u(x), and finally, the treatment efficiency Q, which, in the
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absence of convection, is naturally constrained to a relatively small range, see eqs. 13
and 14. We observed in simulations (Fig. 2) that convection will incur either a depletion
or enrichment of both mutant and wild types in the antibiotic region, depending on
whether the convection points towards higher or lower antibiotic concentrations (co-
or counter-flow, respectively). To study the effects of convection analytically, we set
v 6= 0 in eqs. 5 and 7, and introduce the dimensionless flow speed ν = v/√Da0.
The characteristic flow speed vc is closely related to the Fisher wave speed vF , which
corresponds to the expansion speed of a freely growing population. If convection is too
strong, i.e., the flow speed is great than the Fisher wave speed, (|ν| > 2), no steady-state
population density exists because the population is washed away (see SI section 5), and
we are therefore constrained to |ν| < 2.
In step-like gradients (m  1), even in the presence of convection, the population
density c(ξ) approaches its asymptotic values exponentially fast, as can be seen by
expanding eq. 5 to first order around its fixed points and solving the resulting linear
differential equations (see SI section 4). As in the no-flow case, we can therefore
approximate c(ξ) with a step function to find approximate solutions for u(ξ) far from the
step gradient. With co-flow (ν > 0), the diffusion term in eq. 7 can be neglected to first
order and hence the establishment probability has a very broad tail, u(ξ) ∼ (1 + ξ/ν)−1
(Fig. 4b, SI eq. S15). With counter-flow (ν < 0), the diffusive term is essential because
the convection term cannot balance the non-linearity since both are negative. This gives
rise to a rapid exponential decay u(ξ) ∼ e−νξ (Fig. 4b).
In shallow gradients (m  1), co-flow has little effect on the population density
(and correspondingly establishment probability) profiles because the convection term
νc′(ξ) in eq. 5 is roughly proportional to m  1. In counter-flow condition, our model
reproduces the cut-off in the population density c(ξ) seen in our simulations, which
traces the net growth rate sWT (ξ) until it drops sharply. The position of this cut-off
can be estimated from the definition of the Fisher wave speed νF , which depends on the
wild-type net growth rate sWT (ξ) (see also SI section 5). In shallow gradients, sWT (ξ)
changes little around the cut-off, such that the (rescaled) Fisher wave speed becomes
position-dependent νF (ξ) = 2
√
sWT (ξ)/a0. Hence, no wild-type population density can
be maintained in regions where the flow speed ν becomes larger than the local Fisher
wave speed νF (ξ), and solving for ξ gives the position of the cut-off
ξ∗c = −
1
m
arctanh(ν2/4). (15)
Similarly, we find two cut-offs in the establishment probability profile u(ξ): since in
shallow gradients, u(ξ) ≈ 1 − c(ξ), u(ξ) approaches 1 sharply when c(ξ) drops to zero
at ξ∗c . In addition, since the mutants have a local net growth rate that depends on
the wild-type density, their speed limit is by νF (ξ) = 2
√
1− c(ξ), which gives another
cut-off at the position
ξ∗u = −
1
m
arctanh(1− ν2/4). (16)
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Figure 6. Total death rate B and rate of adaptation, R (symbols, from numerical
solutions to eq. 5 and 7), vary as a function of the rescaled gradient length λ/` = 1/m.
In steep gradients (m  1), B and R approach constants. In the limit of shallow
gradients (m 1), both R and B are proportional to 1/m. In the absence of external
flow, both limits are captured by the analytical results, eqs. 13 and 14.
When ν < −√2, the two cut-offs reduce to one, and both c(ξ) and u(ξ) exhibit a sharp
transition at ξ∗c (see Figs. 2a).
Fig. 5 compares the cut-off positions in the establishment probability profiles from
the numerical model and simulations. While there is excellent agreement between this
theoretical predictions, eqs. 15 and 16, and the numerical evaluation of the model, as
well as with the cut-off ξ∗u of the simulated establishment probability u(ξ), the cut-off
ξ∗c of the simulated population density c(ξ) appears shifted towards higher ν. This
effect can be traced back to number fluctuation at the front of the population where
the population size is small, which leads to a significant shift in the cut-off depending
on the carrying capacity K (SI section 5, Fig. 5, black dotted line).
By integrating the numerical solutions to eqs. 5 and 7, we can compute the total
death rate B and the rate of adaptation, R, and compare with the simulation results.
As shown in Fig. 7, our model reproduces the phenomenology of the simulation very
well, except in strong counter-flow conditions, where the number fluctuations at the
front give rise to mostly quantitative differences.
5. Discussion
We presented stochastic simulations and an analytical model to study the fates of
individual resistance mutations in spatial antibiotic gradients, for the first time also
including the effects of convection. Our analytical model allows us to identify two
characteristic length scales, λ and `, which, together with the growth rate a0, determine
the fate of resistance mutations (see Fig. 8). The gradient length λ describes the
characteristic length scale over which the antibiotic concentration varies. Individuals
travel a characteristic distance ` =
√
D/a0 through random dispersal with migration
rate D before replicating. The ratio m = `/λ determines whether a gradient is shallow
or steep. If the gradient is shallow (λ  `), the antibiotic concentration does not
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Figure 7. Comparison between simulations and numerical solutions. (a) Total death
rate B and rate of adaptation, R, computed from simulations (symbols) and numerical
solutions to eqs. 5 and 7 (lines), in three different gradients (as in Fig. 3). The
agreement is very good, except for strong counter-flow, where number fluctuations
at the front become important, as explained in the main text. (b) The treatment
efficiency Q found in simulations is also well-captured by our model, except for strong
counter-flow.
appreciably change over distances accessible to a single individual in one generation,
such that the population is locally adapted to the antibiotic concentration and changes
only on length scales of order λ. If the gradient is steep (λ `), an individual close to
the gradient can travel between regions of high and low antibiotic concentration in its
lifetime such that the population density is constant far from the gradient and changes
relatively abruptly over a distance ` around the gradient.
From the migration length `, we also identify the characteristic speed vc =
√
Da0 =
`a0, which is closely related to the expansion speed vF = 2vc of a freely expanding
population [48]. Hence, if convection is too strong, i.e., if the convection speed |v| > vF ,
the population will not be able to grow against the flow and be simply washed away
(Fig. 8; this akin to the extinction transition of populations due to convection [52, 53].
For the emergence of resistance, we are thus naturally restricted to the region |v| < vF .
It is illuminating to estimate the typical range of ` and vc for microbial communities.
A typical (non-motile) bacterial cell may have a diameter of 1µm, swimming in a medium
of viscosity comparable to that of water (e.g., blood [54]), which gives a diffusivity
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Figure 8. Schematic summary of our main results. Identifying the characteristic
length scale ` allows us to classify gradients as steep (bottom) or shallow (top),
depending on how ` compares with the gradient length scale λ. Convection leads to
extinction when it is too strong compared with the characteristic convection speed vF ,
no matter whether convection is directed towards higher (co-flow) or lower (counter-
flow) antibiotic concentration. Shown in the background is the rate of adaptation
of the population to the antibiotic (blue colors, low adaptation; orange colors, high
adaptation).
of order 0.1-1µm2/s. The motion of motile bacteria is characterized by much larger
diffusivities, up to tens or even hundreds of µm2/s [55]. Together with a typical growth
rate of 0.5−2hr−1, this gives a possible range for ` between 50µm and several millimeters.
For comparison, in a microfluidic experiment by Zhang et al. [26] the length scale on
which the drug gradient varied was ≈ 200µm such that λ/` ∼ 1. For another recent
experimental study by Baym et al. [12] with a reported spreading velocity of 40mm/hr,
we find ` ≈ 1 − 20mm. Thus, depending on the properties of the bacteria and the
antibiotic gradient, both shallow (λ  `) and steep (λ  `) gradients can plausibly
arise. Similarly, with our range of parameters for D and a0, we find typical values for
vc ≈ 0.1 − 10µm/s, which is on the same order of magnitude as estimated flow speeds
in the gut, and achieved in an artificial gut microfluidic system [34].
We have quantified the emergence of resistance by computing the rate of adaptation
for a wide range of gradient steepnesses and convection speeds. As a general rule, our
model predicts that the rate of adaptationin shallow gradients is roughly proportional
to the gradient length λ, as long as λ is smaller than the system size. This is in
agreement with previous results from Greulich et al. [38], who employed the quasi-
static approximation, eq. 12. As we have shown, this approximation breaks down when
λ ≈ `. In the opposite limit, λ  `, i.e., in steep gradients, we find a finite rate of
adaptation, in agreement with the so-called staircase model of Hermsen et al. [37]. This
is because mutants born in low antibiotic concentration regions can migrate into regions
of high concentration, where they enjoy a big selective advantage. Our model serves as
a generalization of these two previous model by capturing the full crossover from the
”mutate and migrate” mechanism governing adaptation in steep gradients to the ”local”
adaptation in shallow gradients [56].
Convection can have a momentous influence on the rate of adaptation in our
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model. Co-flow (convection towards higher antibiotic concentration) increases the rate
of adaptation by extending the range of the wild-type population further into high
concentration regions, where resistance mutants have a strong advantage. At the same
time, co-flow transports resistant mutants born in low-concentration regions (where the
wild-type population density is high) to the front. In the same manner, counter-flow
(convection towards lower antibiotic concentration) can restrict the range of the wild-
type population and prohibit resistance mutation from establishing when they arise far
away from the antibiotic gradient. This can lead to a decrease of the rate of adaptation
by several orders of magnitude for strong counter-flow, until eventually the population
goes extinct when counter-flow becomes too strong (see Fig. 8).
In the context of antibiotic treatment of an infection, the eradication of the
infecting bacterial population is paramount [40] and therefore, we have argued that
focusing on the rate of adaptation alone may be misleading. To quantify the trade-off
between wild-type killing and the emergence of resistance, we measured the reduction
in pathogenic growth relative to the rate of adaptation. This measure, which we call
the treatment efficiency, has an intuitive meaning: a high treatment efficiency implies
a strong reduction in the growth of the bacteria before a resistance mutation arises
and establishes. In our model, the treatment efficiency is strongly affected by counter-
flow, where it can be an order of magnitude higher than in a no-flow scenario. This is
ultimately a consequence of the rate of adaptation being doubly affected by convection,
because convection alters both the wild-type population density (thus changing the local
competition that resistant mutant clones face) and the dynamics of individual mutants,
which are carried away from the high antibiotic concentrations they require in order to
establish. Despite its intuitive meaning, however, the treatment efficiency as defined
here makes no predictions about optimal treatment regimens; it merely serves as a
quantification of the inherent trade-off between wild-type eradication and selection for
resistance.
Our model is restricted to scenarios where interference between multiple mutant
clones can be neglected, since we follow the establishment of individual mutations.
Therefore, our model, operates exclusively in the ”mutation-limited” regime [39], where
the rate of adaptation is dominated by the waiting time until the establishment
of mutations. By contrast, both Hermsen [37, 39] and Greulich [38] consider the
establishment of many, potentially contemporaneous mutations. In very shallow
gradients, this can lead to a ”dispersion-limited” regime if the mutational supply is
large; the rate of adaptation is then dominated by the speed with which established
mutations invade previously uninhabitable territory. We derive upper limits for the
mutation rate µ per generation for our model to be applicable (SI section 6) and find
that in steep gradients, clonal interference is negligible as long as µK  1, where K
is the typical population size in a population patch of size `. This result is similar to
what is expected in well-mixed populations [57] (see SI section 6). In shallow gradient,
the corresponding condition is µK  (`/λ)2. Thus, if the gradient is too shallow for
a given mutation rate, mutations enter the population too fast and clonal interference
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effects are expected. For resistance mutations with small target sizes, mutation rates
can be very small, typically less than 10−6 [58, 59], and thus our approximation may
be accurate even for relatively large carrying capacities K. Even when the mutation
rate is high, we expect convection and spatial gradients to have the same qualitative
effects on the establishment of resistance mutations, and thus our results should remain
qualitatively correct even beyond the single-mutation regime considered here.
Our analytical model extends previous models [37–39] by incorporating arbitrary
gradients and convection, and it can serve as a general branching process framework
to study adaptation in spatially heterogeneous environments. For instance, we can
easily incorporate antibiotic sanctuaries which are predicted to facilitate the emergence
of resistance [23, 25]. Other, more complex gradients may be necessary to describe
cases in which the death rate depends on the antibiotic concentration on a non-linear
manner [37]. Our model can also easily be re-interpreted to apply to a broad range of
different ecological scenarios, like heterogeneous nutrient concentration. To make our
model more realistic, it would be useful to model the bacteria as having a finite size,
such that the population front can advance through mere growth, even against strong
counter-flow [60]. For strong co-flow, individuals may also de-adhere and be carried
away from the bulk population, thus founding extant colonies that enjoy large growth
rates in the absence of competition for resources. Such processes can be studied by
generalizing the diffusion term in our model to a long-range dispersal term as used
frequently to model epidemics [61]. Since long-range dispersal can allow mutants far
from the population front to escape the bulk population, we expect it to increase the
total establishment probability and thus the rate of adaptation relative to short-range
dispersal as discussed here. Another interesting generalization of the model would be
to extend the model to two-dimensional populations since real biofilms typically grow
as two-dimensional communities, with complex spatial patterns. The establishment of
beneficial mutations in microbial colonies has recently been discussed [15, 62]. Due
to the particular strength of genetic drift at the front of such populations, beneficial
mutations first have to reach a threshold size (depending on the strength of the selective
advantage) neutrally before they become established. Once the mutant clone reaches the
threshold size, the selective advantage of the mutants can deterministically drive them
to fixation in the population. During the initial phase, the mutant clone is contained
between boundaries with characteristic stochastic properties that are not captured in
our one-dimensional model [14]. However, if the threshold size is small, the boundary
fluctuations will not have a large impact on the growth of mutant clones. In such cases,
we expect our results to apply also to two-dimensional populations.
The emergence of drug resistance remains a topic of significant interest, both from
a scientific and a public health point of view. Considerable effort is brought forward to
create novel antibiotics [63] and new therapy strategies are developed that attempt to
limit the emergence of resistance [64, 65], but more research is needed to understand
how resistance evolves in complex spatio-temporal settings like the spatial gradients
discussed in this paper. In particular, as we have shown here, convection constitutes
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an important factor in shaping the adaptation to antibiotics in spatial concentration
gradients and should receive more attention from both theorists and experimentalists.
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6. Methods
Individual-based simulation
We perform individual-based, stepping stone simulations where both wild-type and
mutants are modeled explicitly. The population is divided into demes with carrying
capacity K = 100 on a one-dimensional lattice. Wild-type and mutants replicate at
a rate a0 and migrate at rate D independently on their position. Wild type in deme
x die at a rate b(x) = 1 + tanh(mx). Since we assume throughout that the antibiotic
leaves the mutants unaffected, mutants do not die in our simulations. Analogously
to a Gillespie algorithm, in each simulation step, a birth, death or migration event is
performed according to its relative rate [44, 45], as follows.
• Birth. Birth events occur at a total rate equal to a0
∑
x c(x), where c(x) is the
total number of individuals in deme x. For each birth event, a source individual
is selected at random and replicated into a random target site between 1 and K
within the same deme. Because the target site can either already be filled with an
individual or be empty, this move effectively translates into logistic growth within
the deme.
• Death. In our model, only the wild type can die, thus deaths have a total
rate corresponding to
∑
i b(x)cwt(x), where cwt(x) represents the number of wild
type individuals in deme i. To perform a death event, first, a deme x is picked
proportionally to its relative death rate b(x)cwt(x), and then, a random wild type
within the same deme selected to be removed.
• Migration. Migrations are performed at a rate D∑x c(x) by picking a random
individual and swapping it with a randomly selected target site from one of the
two neighboring demes. As in the case of birth events, the target site can either
correspond to an individual, or to an empty site.
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• Time step. Time is tracked by sampling a time interval δt from an exponential
distribution with rate
∑
x [(a0 +D)c(x) + b(x)cwt(x)], as in a standard Gillespie
algorithm. The total elapsed time is the sum of the sampled time intervals.
• Convection. Convection (with convection speed v) is implemented by shifting
the population by one deme away or towards the antibiotic gradient, for negative
or positive convection respectively. The convection strength is controlled by
performing the shift at a rate 1/|v|, i.e., any time the time elapsed since the last
shift is greater than 1/|v|.
For each simulation, we first allow the wild type to reach the steady-state profile
c(x). We then introduce one mutant element at position x and run the simulation until
either all mutants go extinct, or mutants reach the last deme in the simulation box.
No further mutations are allowed in the course of the simulations. The probability of
fixation u(x) is then computed as the proportion of the simulations in which a mutant
introduced at x reached fixation.
Numerics
Numerical solutions to eqs. 5 and 7 were obtained by evaluating the differential equations
using Mathematica’s built-in NDSolve routine with the backwards differentiation (BDF)
method, with a maximum step size of 1 and a domain size of 1000. Initial conditions
were chosen according to the analytical approximations to the steady-state profiles given
in the text. This is done to speed up computation and increase numerical stability, but is
otherwise inconsequential; starting with different initial conditions leads the same final
solution. To obtain steady-state profiles, we solve the full time-dependent problems
until the solution no longer changes for longer evaluation times.
To compute the establishment probability u(x) in realistic wild-type population
profiles c(x), we first computed the steady-state population density and then used
the final profile to compute the (constant in time) local death rate for the mutants
b(x) = 1 − c(x). The resulting numerical solutions were integrated numerically using
Mathematica’s built-in NIntegrate routine to obtain the total death rate B and the rate
of adaptation, R, .
Supplementary Information
S1. Antibiotic concentration profile
In the main text, we suppose an antibiotic gradient varying over a characteristic length
scale λ. Here, we present an example for how such an antibiotic gradient may arise.
We use a simple reaction-diffusion model for the antibiotic concentration C in a one-
dimensional system of length L to show that our model for the antibiotic gradient, eq. 1
in the main text, can approximately capture a variety of realistic gradient profiles.
Consider an antibiotic source at position −L/2 and an antibiotic sink at position
L/2. The antibiotic concentration at the source is c∞ and the antibiotic concentration at
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Figure S1. Example of realistic growth rate profiles for different convection speeds
vC (vC > 0, cyan; vC = 0, black; vC < 0, magenta). Solid lines are solutions to eq. S1,
dashed lines are fits with eq. 1 in the main text.
the sink is 0. The drug diffuses with diffusion constant DC and is subject to convection
with speed vC . Additionally, the antibiotic may be degraded, e.g., by cells metabolizing
the drug or through chemical degradation, at a rate γ. Under these assumption,
the steady-state antibiotic concentration profile is described by the reaction diffusion
equation
0 = DC∂
2
xC(x)− vC∂xC(x)− γC(x). (S1)
The resulting net growth rate s(x) = 1− 2C(x)/C∞ is shown for three values of vC and
γ = 0 in Fig. S1 (solid lines). The dashed lines are approximations of the form given
in eq. 1 in the main text. For our purposes, eq. 1 gives a good enough fit to (simple)
realistic antibiotic profiles.
S2. Derivation of survival probability
Let ux(t) denote the probability that a mutation born at lattice site x survives for time
t. Denote by a(x) and b(x) the local birth and death rate, respectively, and let v+ and
v− be the rates to migrate a distance δx (i.e., one lattice site) to the right and to the
left, respectively. Then, the u(x, t) after a short time interval  satisfies the equation
ux(t+ ) = a(x)
{
1− [1− ux(t)]2
}
+  {v+ux+δx(t) + v−ux−δx(t)} (S2)
+ {1−  [a(x) + b(x) + v+ + v−]}ux(t).
The first term on the right-hand side accounts for the fact that when the initial mutant
divides then there are two mutants, and the probability of survival of at least one
lineage is 1 minus the square of both lineages disappearing. The second term describes
the probability of migrating one lattice site to the left or right, respectively. The first
term describes the case of nothing happening in the time interval .
Letting  → 0 and performing the Taylor expansion in δx, we obtain eq. 5 in the
main text
∂tu = D∂
2
xu+ v∂xu+ s(x)u− a(x)u2, (S3)
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where s(x) = a(x) − b(x), D = (v+ + v−)δx/2, and v = (v+ − v−)δx. Note that the
sign of the convection term v∂xu is reversed from that in the equation governing the
population density, eq. 5 in the main text.
S3. Step-like concentration profile without flow
In a step-like gradient without flow, the steady-state wild=type population density
profile c(ξ) obeys the equation
0 = ∂2ξ c+ (1− 2Θ(ξ))c− c2, (S4)
where Θ(ξ) is the Heaviside function. For both ξ > 0 and ξ < 0, this equation can be
solved by a mechanical analogy with a particle in the ”potential” U(c) = ± c2
2
− c3
3
. For
ξ < 0, we have the potential U(c) = c2/2−c3/3 and the boundary condition c(−∞) = 1
and c(0) = c0, which gives a total energy E = K + U = 1/6 because the kinetic energy
K = 0 at −∞. The population density c(ξ) is then determined through the integral
ξ =
∫ c(ξ)
c0
dc′√−2U(c′) + 2E =
∫ c(ξ)
c0
dc′√−c2 + c3/3 + 1/3 . (S5)
Similarly, for ξ > 0, we have U(c) = −c2/2 − c3/3 and E = 0, and c(ξ) is determined
through the integral
ξ =
∫ c(ξ)
c0
dc′√
c2 + c3/3
. (S6)
Both integrals can be solved exactly, and the derivatives matched at ξ = 0. The result
is
c(ξ) =
3
2
tanh
[
ξ − ξ−
2
]2
− 1
2
, ξ < 0, (S7)
=
3
2
tanh
[
ξ + ξ+
2
]2
− 3
2
, ξ ≥ 0, (S8)
where ξ± = 2arctanh(13
√
6± 3 +√6).
The population density transitions from 1 to 0 exponentially fast, and we can
approximate c(ξ) ≈ Θ(−ξ) when computing the establishment probability, which then
approximately obeys the equation
0 = ∂2ξu+ Θ(ξ)u− u2. (S9)
Using the same mechanical analogy as above, and again matching derivatives at ξ = 0,
we find
u(ξ) =
1/
√
3(
1− ξ/
√
6
√
3
)2 , ξ < 0, (S10)
=
3
2
tanh
[
ξ + ξu
2
]2
− 1
2
, ξ ≥ 0, (S11)
where ξu = 2arctanh(
1
3
√
3 + 2
√
6).
Convection shapes resistance evolution in spatial gradients 22
●●●
●●
●●
●●●●●●●●
●
□□□□
□□
□□
□□
□
□
□
□
□
□ ◇
◇
◇
◇◇◇◇
◇
◇◇◇◇◇◇◇◇
-2.0 -1.0 0.0 1.0 2.00.0
0.5
1.0
1.5
2.0
2.5
ν
ex
po
ne
nt
ial
 d
ec
ay
 ra
te
u(ξ>0)
c(ξ<0)
c(ξ>0)
decay rate for
Figure S2. Exponential decay rates for the different cases discussed in the text:
c(ξ > 0) (cyan, eq. S13), c(ξ < 0) (red, eq. S14), and u(ξ > 0) (black, eq. S17).
From the profiles for c(ξ), the total death rate B can directly be computed as
B = −3 +
√
9 +
√
6 ≈ 0.38, as quoted in the main text. Since c(ξ) transition sharply
around ξ = 0, the establishment score R =
∫∞
−∞ c(ξ)u(ξ) can be approximated as
R ≈ ∫ 0−∞ u(ξ) = √2√3 ≈ 1.86, which is very close to the numerical result R ≈ 1.91.
S4. Step-like antibiotic concentration profile with flow
In the presence of flow, the equations for the population density becomes
0 = ∂2ξ c− ν∂ξc+ (1− 2Θ(ξ))c− c2. (S12)
For ξ  0, the population density is small such that we can extract the asymptotic
behavior from the linear equation. With the boundary condition c(∞) = 0, we get
c(ξ  0) ∼ e−(
√
4+ν2−ν)ξ/2. (S13)
Similarly, for ξ  0, c(ξ) is close to one; introducing Ψ(ξ) = 1− c(ξ) and linearizing the
result equation, we get that
1− c(ξ  0) ∼ e−(
√
4+ν2+ν)|ξ|/2. (S14)
Thus, even in the presence of flow, the population density transitions sharply around
the antibiotic concentration step. Therefore, we can employ the same approximation as
in the no-flow case and approximate c(ξ) ≈ Θ(−ξ).
The establishment probability u(ξ) thus approximately satisfies the equation
0 = ∂2xu+ ν∂xu+ Θ(ξ)u− u2. (S15)
For ξ > 0, the establishment probability approaches 1 exponentially quickly. To see
this, we can again expand around 1 and solve the resulting linearized equation. The
result is
1− u(ξ > 0) ∼ e−(
√
4+ν2−ν)ξ/2, for ν > 0, (S16)
∼ e−(
√
4+ν2+ν)ξ/2, for ν < 0. (S17)
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Figure S3. The effects of finite carrying capacity on the population density profile in
shallow gradients. (a) In counter-flow conditions (ν = −1.5), a small carrying capacity
leads to a strong shift in the cut-off. (b) Evaluation the analytical model with the
growth rate corrected for finite carrying capacity, eq. S22 (solid lines), and without the
correction (dashed lines) for different flow speeds. (c) Comparison with the simulation
shows good agreement between the numerical data (dashed line) and the analytical
approximation, eq. S23 (solid line).
The results in summarized in Fig. S2.
For ξ < 0, the linear term in eq. S15 vanishes, and we have to distinguish two cases,
ν > 0 and ν < 0. For ν > 0, we expect a broad profile because co-flow facilitates the
establishment of mutations born deep inside the population bulk. Hence, the non-linear
term in eq. S15 cannot be neglected. On the other hand, if the co-flow is strong, we can
neglect the diffusive term and find asymptotically
u(ξ < 0) ∼ 1
1 + |ξ|
ν
, for ν > 0, (S18)
in good agreement with the numerical solution (cyan line in Fig. 4b in the main text).
For counter-flow, i.e., for ν < 0, it is intuitively clear that the establishment
probability must vanish faster than in the no-flow case. Thus, we expect for that
u(ξ  0) such that we can neglect the non-linearity. As a result, we get
u(ξ < 0) ∼ e−νξ, ν < 0, (S19)
which also agrees well with the numerical solution (red line in Fig. 4b in the main text).
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S5. Cut-off position and finite carrying capacity
Here, we provide a more rigorous derivation of the cut-off position ξ∗c . For ν < 0 and
m 1, the population density c(ξ, τ) satisfies the equation
∂τc = ∂
2
ξ c− ν∂ξc(ξ) + sWT (ξ)c− c2. (S20)
Performing the transformation ϕ = ce−νξ/2 we obtain
∂τϕ(ξ, τ) = ∂
2
ξϕ+
(
sWT (ξ)− ν
2
4
)
ϕ− ϕ2e−νξ/2. (S21)
Assume the population is started with an initial population at ξ = −∞. To arrive at
the steady-state population density discussed in the main text, ∂τϕ must be positive
initially and go to zero as τ → ∞. For the right-hand side of eq. S21 to be positive,
we must have sWT (ξ) − ν24 > 0, whence we obtain eq. 15 in the main text. Eq. 17
is obtained by the same arguments. Note that this derivation also gives the general
condition ν2 < 4, i.e., the external flow speed must be smaller than the Fisher wave
speed of the population.
We model the effects of a finite carrying capacity K by introducing a cut-off in the
net growth rate if the local wild-type population density becomes lower than 1/K. To
this end, we replace sWT (ξ) in eq. 5 in the main text with
sWT (ξ,K) = sWT (ξ)Θ(c(ξ)− 1/K). (S22)
The results are shown in Fig. S3: for fixed ν, smaller K reduce the maximal sustainable
local flow speed, such that the cut-off is shifted to the left for smaller K (Fig. S3a).
When K is relatively small, the cut-offs can be shifted strongly, especially at strong flow
speeds (Fig. S3b).
For an analytical approximation, we use the result that a finite carrying capacity
reduced the Fisher wave speed by a factor 1 − pi2/2(lnK)2. Plugging this correction
into eq. 16 we get a corrected cut-off position ξ∗c ,
ξ∗c (K) = −
1
m
arctanh
[
ν2
4 (1− pi2/2(ln K)2)2
]
, (S23)
which shows reasonable agreement with our simulations (Fig. S3c, black line).
S6. Small mutation rate estimate
For clonal interference to be negligible, we estimate that the time to fixation of a mutant
clone must be much faster than the time it takes for a mutation to arise and establish. In
a well-mixed population, this condition can be phrased as µN  1, or, more precisely,
τfix ≈ ln[Ns]/s τestablish ≈ 1/(µNs). (S24)
In a spatial scenario, the establishment time τestablish is given through a generalization
of the well-mixed result, i.e.,
τ−1establish ≈ µc∞
∫
u(x)c(x)dx = µ(K/`)R, (S25)
REFERENCES 25
where we have made the dependence on the carrying capacity K explicit, and the
mutation rate µ is given per generation. We have found in the main text that R ∼ ` in
steep gradients and R ∼ λ in shallow gradients.
We can estimate the time to fixation by considering a mutation born at a typical
distance L from the front of the population; it then has to travel this distance L to take
over the whole population. In our model, the distance L can be estimated from the
position of the peak of the product u(ξ)c(ξ). This is approximately given by
L ∼ `, λ `, (S26)
λ, λ `. (S27)
The time it takes to travel this distance depends on the steepness of the gradient: in
a steep gradient, mutants have to migrate into region of high antibiotic concentration
through random dispersal. We can model their motion as a random walk, and hence,
the distance ` =
√
2Dτfix such that τfix = `
2/2D. This gives the criterion for negligible
clonal interference as
µK  1. (S28)
In shallow gradients, the time to fix for a mutant clone is given by the length L
divided by the speed v with which it travels, which is roughly v ∼ √Da0. This gives
the condition
µK  `
2
λ2
. (S29)
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